OS Therapies Inc — Form 10-Q
Filed August 14, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
Paul Romness (CEO) and Christopher Acevedo (CFO) certified the June 30, 2026 10-Q on August 14, 2026, affirming the financial statements fairly present the company's condition and results. The certifications are standard Sarbanes-Oxley 302/906 attestations with no disclosure of material weaknesses, significant deficiencies, or fraud. The filing excerpt contains only boilerplate certification exhibits with no substantive operational, financial, or strategic information.
Why this rating
Routine SOX certification with no material facts disclosed; standard periodic filing procedure.
See more from August 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.